Since 1962.

Sponsored articles

Post-authorization Safety and Efficacy Study of Olanzapine (Zolrix®) in the Treatment of Schizophrenia and Bipolar Mania

Schizophrenia and bipolar disorder are mental disorders that pose a real problem to the public health care system. Early diagnosis and treatment is instrumental in a relatively good management and…
Read more ›

Post-Authorization Safety and Efficacy Study of Escitalopram (Ecytara®) in the Treatment of Depression and Anxiety Disorders

BACKGROUNDS. Depression is the most common mental disorder and is a serious mental illness. It is a mental disorder that pose a real problem to the public health care system.…
Read more ›

Clinical experience with high doses of atorvastatin

Cardiovascular diseases (CVDs) represent an important healthcare problem in Europe. Among the objectives of cardiovascular disease prevention a more rigorous risk factor control is needed, including control of cholesterol levels. In…
Read more ›

Evaluation of Efficacy, Safety and Acceptability of Orodispersible Risperidone in Patients with Schizophrenia, Bipolar Mania and Behavioural Disturbances in Dementia Patients

Second generation antipsychotics are currently the drugs of choice for the treatment of schiz­ophrenia and bipolar mania, as well as for behavioural symptoms in patients with dementia. All these diseases…
Read more ›